z-logo
open-access-imgOpen Access
�-Elemene Reverses Chemoresistance of Breast Cancer via Regulating MDR-Related MicroRNA Expression
Author(s) -
Jun Zhang,
He da Zhang,
Lin Chen,
Da Sun,
Chang fei Mao,
Wei Chen,
Jian Wu,
Shan Zhong,
Jian Zhao,
Jin Tang
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000366398
Subject(s) - elemene , microrna , mcf 7 , multiple drug resistance , cancer research , pten , mtt assay , docetaxel , breast cancer , cancer , biology , pharmacology , cell growth , drug resistance , medicine , apoptosis , pi3k/akt/mtor pathway , gene , human breast , biochemistry , microbiology and biotechnology
Multidrug resistance (MDR) directly contributes to the clinical failure of chemotherapy in breast cancer (BCA). β-elemene is a natural antitumor drug from plants. We previously confirmed that MDR could be reversed by β-elemene. In this study, we intended to investigate the reversal effect of β-elemene on MDR in human BCA adriacin (Adr) -resistant MCF-7 cells (MCF-7/Adr) and docetaxel (Doc) - resistant MCF-7 cells (MCF-7/Doc) through the gene regulatory network.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom